Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, China.
Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, China; Collaborative Innovation Center of Hematology, Peking University, China.
Clin Immunol. 2018 May;190:32-40. doi: 10.1016/j.clim.2018.02.009. Epub 2018 Mar 15.
Acute B lymphoblastic leukemia (B-ALL) relapse contributes predominantly to the mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the mechanism of B-ALL relapse after allo-HSCT remains unknown. The eradication of leukemia after allo-HSCT largely relies on graft-versus-leukemia (GVL) effects mediated by donor T cells. T cell exhaustion, characterized by the increased expression of inhibitory receptors and impaired function, may suppress GVL effects. In this study, we evaluated whether T cell exhaustion was involved in B-ALL relapse after allo-HSCT. The results showed that CD4 and CD8 T cells exhibited increased coexpression of PD-1 and Tim-3, and compromised proliferative capacity, cytokine production and cytotoxic potentials in relapsed patients. Additionally, T cells at the tumor site were more easily exhausted than T cells in the peripheral blood. Moreover, the reversal of T cell exhaustion might correlate with effective anti-leukemic responses after reinduction. These results suggested that T cell exhaustion was associated with B-ALL relapse after allo-HSCT as well as its treatment outcome.
急性 B 淋巴细胞白血病 (B-ALL) 复发是异基因造血干细胞移植 (allo-HSCT) 后患者死亡的主要原因。然而,allo-HSCT 后 B-ALL 复发的机制仍不清楚。allo-HSCT 后白血病的清除在很大程度上依赖于供者 T 细胞介导的移植物抗白血病 (GVL) 效应。T 细胞耗竭的特征是抑制性受体表达增加和功能受损,可能会抑制 GVL 效应。在这项研究中,我们评估了 T 细胞耗竭是否与 allo-HSCT 后 B-ALL 复发有关。结果表明,复发患者的 CD4 和 CD8 T 细胞表现出 PD-1 和 Tim-3 的共表达增加,增殖能力、细胞因子产生和细胞毒性潜能受损。此外,肿瘤部位的 T 细胞比外周血中的 T 细胞更容易耗竭。此外,T 细胞耗竭的逆转可能与再诱导后有效的抗白血病反应相关。这些结果表明,T 细胞耗竭与 allo-HSCT 后 B-ALL 复发及其治疗结果有关。